Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8417 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8143 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8112 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8099 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD37 |
Approved |
0.773 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD228 |
Approved |
0.766 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7639 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7537 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7448 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7333 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD5763 |
Approved |
0.732 |
Intermediate Similarity |
NPD5762 |
Approved |
0.732 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7285 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7284 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.726 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7118 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7118 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6100 |
Approved |
0.703 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD940 |
Approved |
0.7015 |
Intermediate Similarity |
NPD846 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7 |
Intermediate Similarity |
NPD27 |
Approved |
0.6994 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD7266 |
Discontinued |
0.698 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD7157 |
Approved |
0.6968 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD4626 |
Approved |
0.6966 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD4059 |
Approved |
0.6964 |
Remote Similarity |
NPD5494 |
Approved |
0.6962 |
Remote Similarity |
NPD7466 |
Approved |
0.6962 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7095 |
Approved |
0.6943 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6937 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6933 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6918 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD7906 |
Approved |
0.6908 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6906 |
Remote Similarity |
NPD5451 |
Approved |
0.6903 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6899 |
Remote Similarity |
NPD3060 |
Approved |
0.6897 |
Remote Similarity |
NPD1357 |
Approved |
0.6897 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6788 |
Approved |
0.6882 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD7680 |
Approved |
0.6882 |
Remote Similarity |
NPD3051 |
Approved |
0.6879 |
Remote Similarity |
NPD7843 |
Approved |
0.6875 |
Remote Similarity |
NPD4577 |
Approved |
0.6875 |
Remote Similarity |
NPD4578 |
Approved |
0.6871 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD7819 |
Suspended |
0.6866 |
Remote Similarity |
NPD3020 |
Approved |
0.6863 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6859 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6857 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6855 |
Remote Similarity |
NPD7003 |
Approved |
0.6855 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6854 |
Remote Similarity |
NPD4663 |
Approved |
0.6853 |
Remote Similarity |
NPD6671 |
Approved |
0.6849 |
Remote Similarity |
NPD5846 |
Approved |
0.6849 |
Remote Similarity |
NPD3019 |
Approved |
0.6849 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD3095 |
Discontinued |
0.6848 |
Remote Similarity |
NPD5090 |
Approved |
0.6848 |
Remote Similarity |
NPD5089 |
Approved |
0.6848 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD8651 |
Approved |
0.6845 |
Remote Similarity |
NPD3749 |
Approved |
0.6842 |
Remote Similarity |
NPD2970 |
Approved |
0.6842 |
Remote Similarity |
NPD2969 |
Approved |
0.6839 |
Remote Similarity |
NPD2157 |
Approved |
0.6835 |
Remote Similarity |
NPD2684 |
Approved |
0.6824 |
Remote Similarity |
NPD2230 |
Approved |
0.6824 |
Remote Similarity |
NPD2233 |
Approved |
0.6824 |
Remote Similarity |
NPD2232 |
Approved |
0.6818 |
Remote Similarity |
NPD943 |
Approved |
0.6818 |
Remote Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD1240 |
Approved |
0.6818 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6802 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD2898 |
Approved |
0.68
|
Remote Similarity |
NPD4339 |
Clinical (unspecified phase) |